Tesla Slips on Q4 Delivery Miss: ETFs in Focus

by Sweta Killa Published on January 03,2025

Tesla misses estimates for Q4 deliveries and sees the first year-over-year decline in deliveries for 2024.

• TSLA Quick QuoteTSLANegative Net Change
• VCR Quick QuoteVCRNegative Net Change
• ARKQ Quick QuoteARKQNegative Net Change
• ARKK Quick QuoteARKKNegative Net Change
• NITE Quick QuoteNITENegative Net Change
• TESL Quick QuoteTESLNegative Net Change

• consumer-discretionary
• electric-vehicles
• etfs

Top Events of 2024 & ETF Predictions for 2025

by Sanghamitra Saha Published on January 02,2025

Expect strength in Wall Street in 2025, with potential in blend stocks, an AI boom, a Chinese equities rebound and a strong year for Tesla.

• GLD Quick QuoteGLDPositive Net Change
• FXI Quick QuoteFXINegative Net Change
• XLU Quick QuoteXLUPositive Net Change
• XSW Quick QuoteXSWNegative Net Change
• XLG Quick QuoteXLGNegative Net Change
• VO Quick QuoteVONegative Net Change
• OEF Quick QuoteOEFNegative Net Change
• MAGS Quick QuoteMAGSNegative Net Change
• NITE Quick QuoteNITENegative Net Change

• etfs

Tesla Stock Hits All-Time High: ETFs to Ride the Momentum

by Sanghamitra Saha Published on December 12,2024

Tesla shares hit an all-time high. Several analysts raised price targets. How can you play TSLA stock with lower level of risks? Tap Tesla-focused ETFs.

• TSL Quick QuoteTSLNegative Net Change
• TSLA Quick QuoteTSLANegative Net Change
• GOOGL Quick QuoteGOOGLPositive Net Change
• XLY Quick QuoteXLYNegative Net Change
• ARKQ Quick QuoteARKQNegative Net Change
• NITE Quick QuoteNITENegative Net Change
• NIO Quick QuoteNIONegative Net Change
• TSLL Quick QuoteTSLLNegative Net Change
• TSLY Quick QuoteTSLYNegative Net Change
• TSLT Quick QuoteTSLTNegative Net Change
• TSLP Quick QuoteTSLPNegative Net Change
• TSLW Quick QuoteTSLWNegative Net Change

• etfs

Can Tesla Return to Its Golden Days? ETFs in Focus

by Sanghamitra Saha Published on August 26,2024

Tesla (TSLA) stock has slumped 11.3% so far this year. Will we see more pain ahead?

• TSLA Quick QuoteTSLANegative Net Change
• XLY Quick QuoteXLYNegative Net Change
• ARKQ Quick QuoteARKQNegative Net Change
• ARKK Quick QuoteARKKNegative Net Change
• NITE Quick QuoteNITENegative Net Change
• TSLL Quick QuoteTSLLNegative Net Change
• TSLS Quick QuoteTSLSPositive Net Change
• TSDD Quick QuoteTSDDPositive Net Change
• TSLR Quick QuoteTSLRNegative Net Change
• TSLT Quick QuoteTSLTNegative Net Change

• etfs

4 Gene Therapy Players Likely to Become Buyout Targets in 2019

by Indrajit Bandyopadhyay Published on April 08,2019

Gene therapy continues to be in focus given the recent spate of deals and acquisitions. We highlight four stocks, which have promising gene therapy candidates in their pipeline.

• OPHT Quick QuoteOPHTNo Net Change
• QURE Quick QuoteQURENegative Net Change
• ONCE Quick QuoteONCEPositive Net Change
• RGNX Quick QuoteRGNXPositive Net Change
• SRPT Quick QuoteSRPTNegative Net Change
• NITE Quick QuoteNITENegative Net Change
• BOLD Quick QuoteBOLDNo Net Change
• SLDB Quick QuoteSLDBNegative Net Change

• biotechs
• pharmaceuticals

Health Day Checkup of Medical ETFs: 5 Top Picks

by Sanghamitra Saha Published on April 05,2019

M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.

• LLY Quick QuoteLLYPositive Net Change
• BMY Quick QuoteBMYPositive Net Change
• GSK Quick QuoteGSKPositive Net Change
• VHT Quick QuoteVHTPositive Net Change
• BTEC Quick QuoteBTECPositive Net Change
• BBH Quick QuoteBBHPositive Net Change
• FBT Quick QuoteFBTPositive Net Change
• IYH Quick QuoteIYHPositive Net Change
• XBI Quick QuoteXBINegative Net Change
• XLV Quick QuoteXLVPositive Net Change
• CELG Quick QuoteCELGPositive Net Change
• ONCE Quick QuoteONCEPositive Net Change
• NITE Quick QuoteNITENegative Net Change

• etfs
• medical

Biotech Stock Roundup: BIIB to Acquire Nightstar, Other Pipeline News & More

by Zacks Equity Research Published on March 06,2019

Key highlights of the past week are merger agreements plus regulatory and pipeline developments.

• CELG Quick QuoteCELGPositive Net Change
• BIIB Quick QuoteBIIBPositive Net Change
• REGN Quick QuoteREGNPositive Net Change
• IMGN Quick QuoteIMGNPositive Net Change
• NITE Quick QuoteNITENegative Net Change

• biotechs

Biogen to Acquire Gene-Therapy Company Nightstar for $800M

by Zacks Equity Research Published on March 05,2019

Biogen (BIIB) to acquire gene-therapy company, Nightstar Therapeutics to accelerate entry into ophthalmology space.

• RHHBY Quick QuoteRHHBYPositive Net Change
• BIIB Quick QuoteBIIBPositive Net Change
• ONCE Quick QuoteONCEPositive Net Change
• NITE Quick QuoteNITENegative Net Change

• biotechs

Company News For Mar 5, 2019

by Zacks Equity Research Published on March 05,2019

Companies in the news are; PLCE, BIIB, NITE, ASND and TAK

• ASND Quick QuoteASNDPositive Net Change
• BIIB Quick QuoteBIIBPositive Net Change
• PLCE Quick QuotePLCENegative Net Change
• NITE Quick QuoteNITENegative Net Change
• TAK Quick QuoteTAKPositive Net Change

• medical

Nightstar Therapeutics (NITE) in Focus: Stock Moves 6.3% Higher

by Zacks Equity Research Published on July 05,2018

Nightstar Therapeutics (NITE) was a big mover last session, as the company saw its shares rise more than 6% on the day.

• CRSP Quick QuoteCRSPNegative Net Change
• NITE Quick QuoteNITENegative Net Change